Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SORAFENIB for Angiosarcoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where SORAFENIB was used for Angiosarcoma.

Most Reported Side Effects for SORAFENIB

Side Effect Reports % Deaths Hosp.
Hepatocellular carcinoma 1,665 15.3% 492 306
Diarrhoea 1,611 14.8% 301 619
Off label use 1,587 14.6% 301 563
Fatigue 1,041 9.5% 179 450
Palmar-plantar erythrodysaesthesia syndrome 1,040 9.5% 202 233
Decreased appetite 906 8.3% 241 420
Death 904 8.3% 901 236
Asthenia 777 7.1% 231 415
Nausea 716 6.6% 139 350
Rash 613 5.6% 103 214
Weight decreased 598 5.5% 144 274
Vomiting 544 5.0% 126 308
Hypertension 517 4.7% 95 178
Pain in extremity 497 4.6% 65 182
Pyrexia 493 4.5% 118 288

Other Indications for SORAFENIB

Hepatocellular carcinoma (4,986) Hepatic cancer (1,167) Acute myeloid leukaemia (620) Renal cell carcinoma (454) Thyroid cancer (399) Product used for unknown indication (234) Metastases to lung (182) Renal cancer (179) Metastatic renal cell carcinoma (134) Neoplasm malignant (121)

Other Drugs Used for Angiosarcoma

PAZOPANIB (164) PACLITAXEL (148) DOXORUBICIN (126) DOCETAXEL (94) GEMCITABINE (67) SIROLIMUS (59) IFOSFAMIDE (53) NIVOLUMAB (46) PEMBROLIZUMAB (37) BEVACIZUMAB (36)

Related Pages

SORAFENIB Full Profile All Angiosarcoma Drugs SORAFENIB Demographics SORAFENIB Timeline